Generic Name and Formulations:
Betamethasone (as dipropionate) 0.05%, clotrimazole 1%; crm; lotion.
Merck & Co., Inc.
Indications for LOTRISONE:
Fungal skin infections.
Apply sparingly twice daily; max 45g (cream), 45mL (lotion) per week. Max 2 wks for t. cruris, t. corporis; 4 wks for t. pedis.
Do not occlude. Use lowest effective dose (esp. in children). Monitor patients regularly. Discontinue steroid if infection persists, worsens or superinfection occurs. Pregnancy (Cat.C). Nursing mothers.
Steroid + azole antifungal.
Irritation, erythema, stinging, folliculitis, hypertrichosis, dermatitis, HPA axis suppression (esp. in children), epidermal and dermal atrophy (esp. in thin-skinned or occluded areas).
Crm—15g, 45g; Lotion—30mL
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder